Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.
INTRODUCTION:An accurate and timely diagnosis for Alzheimer's disease (AD) is important, both for care and research. The current diagnostic criteria allow the use of CSF biomarkers to provide pathophysiological support for the diagnosis of AD. How these criteria should be operationalized by cli...
Main Authors: | Hanneke F M Rhodius-Meester, Ingrid S van Maurik, Juha Koikkalainen, Antti Tolonen, Kristian S Frederiksen, Steen G Hasselbalch, Hilkka Soininen, Sanna-Kaisa Herukka, Anne M Remes, Charlotte E Teunissen, Frederik Barkhof, Yolande A L Pijnenburg, Philip Scheltens, Jyrki Lötjönen, Wiesje M van der Flier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0226784 |
Similar Items
-
Detecting frontotemporal dementia syndromes using MRI biomarkers
by: Marie Bruun, et al.
Published: (2019-01-01) -
Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier
by: Antti Tolonen, et al.
Published: (2018-04-01) -
Evaluating combinations of diagnostic tests to discriminate different dementia types
by: Marie Bruun, et al.
Published: (2018-01-01) -
Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
by: Tong Tong, et al.
Published: (2017-01-01) -
Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study
by: Marie Bruun, et al.
Published: (2019-03-01)